Publications by authors named "K Berginc"

Claim this Profile
O
Overcoming drug impurity challenges in amorphous solid dispersion with rational development of biorelevant dissolution-permeation method.
T Huzjak, O Jakasanovski, K Berginc, V Puž, K Zajc-Kreft

Eur J Pharm Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.
M Mehta, J E Polli, P Seo, S Bhoopathy, K Berginc

J Pharm Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development.
Raman Iyer, Vesna Petrovska Jovanovska, Katja Berginc, Miha Jaklič, Flavio Fabiani

Pharmaceutics· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of gastrointestinal transit on micro-environmental pH inside HPMC matrix tablets - in vitro study.
Helena Vrbanac, Jurij Trontelj, Ajda Osojnik, Katja Berginc, Biljana Janković

Int J Pharm· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopharmaceutical classification of desloratadine - not all drugs are classified the easy way.
Katja Berginc, Nadica Sibinovska, Simon Žakelj, Jurij Trontelj, Igor Legen

Acta Pharm· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis